Your browser doesn't support javascript.
loading
PCSK9 inhibitors and diabetes: Translational biology to clinical practice.
Chilton, Robert J; Oliveros, Rene; Gallegos, Kelly M; Pham, Son.
Affiliation
  • Chilton RJ; Division of Cardiology, UT Health San Antonio, San Antonio, Texas.
  • Oliveros R; Division of Cardiology, UT Health San Antonio, San Antonio, Texas.
  • Gallegos KM; Division of Cardiology, UT Health San Antonio, San Antonio, Texas.
  • Pham S; Division of Cardiology, UT Health San Antonio, San Antonio, Texas.
Diabetes Obes Metab ; 21(3): 451-453, 2019 03.
Article in En | MEDLINE | ID: mdl-30520245
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Practice Patterns, Physicians' / Clinical Trials as Topic / Diabetes Mellitus / Translational Research, Biomedical / PCSK9 Inhibitors / Anticholesteremic Agents Type of study: Clinical_trials Limits: Animals / Humans Language: En Journal: Diabetes Obes Metab Journal subject: ENDOCRINOLOGIA / METABOLISMO Year: 2019 Document type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Practice Patterns, Physicians' / Clinical Trials as Topic / Diabetes Mellitus / Translational Research, Biomedical / PCSK9 Inhibitors / Anticholesteremic Agents Type of study: Clinical_trials Limits: Animals / Humans Language: En Journal: Diabetes Obes Metab Journal subject: ENDOCRINOLOGIA / METABOLISMO Year: 2019 Document type: Article